Study finds GALEAS bladder 92.2% sensitive, may guide cystoscopy decisions
A new study shows the GALEAS Bladder test has a 92.2% sensitivity rate for detecting bladder cancer. This diagnostic tool could allow many patients with blood in their urine to avoid unnecessary and uncomfortable cystoscopy procedures.
Why it matters
It could significantly reduce healthcare costs and patient stress by streamlining the diagnostic process for bladder cancer.
Big news for anyone worried about bladder cancer: GALEAS Bladder showed 92.2% sensitivity. GALEAS Bladder could help doctors decide which patients need an urgent cystoscopy and which may be able to safely defer the procedure. The study, published on September 2, tested nearly 1,000 people who had blood in their urine, so this could seriously change how bladder cancer is investigated.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in